Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
27th September 2023 • Oncology Today with Dr Neil Love • Research To Practice
00:00:00
00:39:10